We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
476
DELISTED
First Republic Bank
FRC
| $1.94M | 0.03% |
19,986
+1,169
| +6% | +$113K |
|
477
Waters Corp
WAT
$36.8B
| $1.93M | 0.03% |
9,992
-1,201
| -11% | -$237K |
|
478
iShares MSCI India ETF
INDA
$6.75B
| $1.93M | 0.03% |
58,000
-9,000
| -13% | -$305K |
|
479
General Mills
GIS
$19.4B
| $1.92M | 0.03% |
43,355
-12,825
| -23% | -$561K |
|
480
Keurig Dr Pepper
KDP
$40.6B
| $1.9M | 0.03% |
15,566
-9,825
| -39% | -$1.18M |
|
481
Cartesian Therapeutics
RNAC
$234M
| $1.9M | 0.03% |
4,767
| – | – |
|
482
MacroGenics
MGNX
$243M
| $1.89M | 0.03% |
91,600
+16,600
| +22% | +$374K |
|
483
MGM Resorts International
MGM
$11.7B
| $1.89M | 0.03% |
65,049
+4,713
| +8% | +$152K |
|
484
Public Service Enterprise Group
PEG
$39.7B
| $1.86M | 0.03% |
34,432
-199,714
| -85% | -$10.3M |
|
|
RHT
485
DELISTED
Red Hat Inc
RHT
| $1.86M | 0.03% |
13,810
-1,702
| -11% | -$275K |
|
|
WCN
486
Waste Connections
WCN
$42.8B
| $1.84M | 0.03% |
24,484
+1,579
| +7% | +$118K |
|
487
WEC Energy
WEC
$37.5B
| $1.84M | 0.03% |
28,465
+2,342
| +9% | +$146K |
|
|
ACHN
488
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.84M | 0.03% |
650,000
| – | – |
|
489
Hartford Financial Services
HIG
$38.7B
| $1.83M | 0.03% |
35,708
-2,941
| -8% | -$154K |
|
490
Wyndham Hotels & Resorts
WH
$5.59B
| $1.82M | 0.03% |
+30,959
| New | +$1.91M |
|
|
EGRX
491
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.82M | 0.03% |
24,000
| – | – |
|
492
AvalonBay Communities
AVB
$27B
| $1.8M | 0.03% |
10,450
+780
| +8% | +$129K |
|
493
Hasbro
HAS
$12.6B
| $1.79M | 0.03% |
19,435
+16,433
| +547% | +$1.44M |
|
|
TTPH
494
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.77M | 0.03% |
24,781
-1,250
| -5% | -$88.3K |
|
|
JWN
495
DELISTED
Nordstrom
JWN
| $1.76M | 0.03% |
33,924
-72,841
| -68% | -$3.61M |
|
496
RTX Corp
RTX
$293B
| $1.75M | 0.03% |
+22,246
| New | +$1.74M |
|
497
Leggett & Platt
LEG
$1.56B
| $1.75M | 0.03% |
39,183
-811
| -2% | -$34.8K |
|
498
C.H. Robinson
CHRW
$21.4B
| $1.74M | 0.03% |
20,789
-450
| -2% | -$40.2K |
|
499
TransDigm Group
TDG
$71.9B
| $1.72M | 0.03% |
4,989
+354
| +8% | +$116K |
|
500
Align Technology
ALGN
$12.2B
| $1.7M | 0.03% |
4,963
-361
| -7% | -$108K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.